Birchview Capital as of June 30, 2021
Portfolio Holdings for Birchview Capital
Birchview Capital holds 62 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bristol Myers Squibb (BMY) | 31.8 | $53M | 796k | 66.82 | |
| Accelr8 Technology | 10.7 | $18M | 2.2M | 8.04 | |
| Biodesix (BDSX) | 8.7 | $15M | 1.1M | 13.21 | |
| Neurocrine Biosciences (NBIX) | 4.7 | $7.8M | 80k | 97.32 | |
| Quidel Corporation | 4.6 | $7.6M | 60k | 128.12 | |
| ACADIA Pharmaceuticals (ACAD) | 2.9 | $4.9M | 199k | 24.39 | |
| Biogen Idec (BIIB) | 2.5 | $4.2M | 12k | 346.28 | |
| Albireo Pharma | 2.3 | $3.9M | 111k | 35.18 | |
| Foghorn Therapeutics (FHTX) | 2.0 | $3.4M | 314k | 10.67 | |
| United Therapeutics Corporation (UTHR) | 1.9 | $3.2M | 18k | 179.39 | |
| Karyopharm Therapeutics (KPTI) | 1.4 | $2.4M | 230k | 10.32 | |
| Bluebird Bio (BLUE) | 1.4 | $2.4M | 74k | 31.99 | |
| Acceleron Pharma | 1.4 | $2.3M | 19k | 125.48 | |
| Masimo Corporation (MASI) | 1.2 | $1.9M | 8.0k | 242.50 | |
| Angion Biomedica Corp | 1.2 | $1.9M | 61k | 31.97 | |
| Vanda Pharmaceuticals (VNDA) | 1.0 | $1.7M | 80k | 21.51 | |
| Harrow Health (HROW) | 1.0 | $1.7M | 180k | 9.29 | |
| Prothena Corp SHS (PRTA) | 0.9 | $1.6M | 30k | 51.41 | |
| Arena Pharmaceuticals | 0.9 | $1.5M | 22k | 68.18 | |
| Continental Resources | 0.9 | $1.5M | 39k | 38.03 | |
| Amarin Corp Spons Adr New (AMRN) | 0.8 | $1.3M | 300k | 4.38 | |
| ImmunoGen | 0.7 | $1.3M | 190k | 6.59 | |
| Nektar Therapeutics (NKTR) | 0.7 | $1.2M | 72k | 17.17 | |
| Alkermes SHS (ALKS) | 0.7 | $1.2M | 50k | 24.52 | |
| Cullinan Oncology (CGEM) | 0.7 | $1.2M | 45k | 25.76 | |
| Arvinas Ord (ARVN) | 0.7 | $1.2M | 15k | 77.00 | |
| Equitrans Midstream Corp (ETRN) | 0.7 | $1.1M | 133k | 8.51 | |
| Corcept Therapeutics Incorporated (CORT) | 0.7 | $1.1M | 50k | 22.00 | |
| Encana Corporation (OVV) | 0.6 | $1.1M | 34k | 31.46 | |
| Soleno Therapeutics | 0.6 | $1.0M | 877k | 1.14 | |
| Biohaven Pharmaceutical Holding | 0.6 | $971k | 10k | 97.10 | |
| Progenity | 0.6 | $964k | 270k | 3.57 | |
| Kalvista Pharmaceuticals (KALV) | 0.6 | $958k | 40k | 23.95 | |
| Progyny (PGNY) | 0.5 | $885k | 15k | 59.00 | |
| Contrafect | 0.5 | $880k | 200k | 4.40 | |
| G1 Therapeutics (GTHX) | 0.5 | $878k | 40k | 21.95 | |
| Translate Bio | 0.5 | $826k | 30k | 27.53 | |
| Inari Medical Ord (NARI) | 0.4 | $653k | 7.0k | 93.29 | |
| Turning Point Therapeutics I | 0.4 | $624k | 8.0k | 78.00 | |
| Pioneer Natural Resources (PXD) | 0.4 | $618k | 3.8k | 162.63 | |
| Tg Therapeutics (TGTX) | 0.3 | $582k | 15k | 38.80 | |
| Aspira Womens Health | 0.3 | $579k | 103k | 5.62 | |
| Apellis Pharmaceuticals (APLS) | 0.3 | $506k | 8.0k | 63.25 | |
| Stoke Therapeutics (STOK) | 0.3 | $505k | 15k | 33.67 | |
| Protagonist Therapeutics (PTGX) | 0.3 | $449k | 10k | 44.90 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.3 | $426k | 8.0k | 53.25 | |
| Xencor (XNCR) | 0.3 | $424k | 12k | 34.47 | |
| Laird Superfood (LSF) | 0.3 | $418k | 14k | 29.86 | |
| Chemocentryx | 0.2 | $402k | 30k | 13.40 | |
| Akebia Therapeutics (AKBA) | 0.2 | $379k | 100k | 3.79 | |
| Dicerna Pharmaceuticals | 0.2 | $373k | 10k | 37.30 | |
| Amicus Therapeutics (FOLD) | 0.2 | $366k | 38k | 9.63 | |
| Sientra | 0.2 | $318k | 40k | 7.95 | |
| BioCryst Pharmaceuticals (BCRX) | 0.2 | $316k | 20k | 15.80 | |
| Aziyo Biologics (ELUT) | 0.2 | $288k | 30k | 9.60 | |
| Kiniksa Pharmaceuticals (KNSA) | 0.2 | $279k | 20k | 13.95 | |
| Arcutis Biotherapeutics (ARQT) | 0.1 | $246k | 9.0k | 27.33 | |
| Inflarx Nv (IFRX) | 0.1 | $208k | 70k | 2.97 | |
| Cytokinetics (CYTK) | 0.1 | $198k | 10k | 19.80 | |
| Hookipa Pharma Inc equity (HOOK) | 0.1 | $183k | 20k | 9.15 | |
| Therapeuticsmd | 0.1 | $119k | 100k | 1.19 | |
| Concert Pharmaceuticals I equity | 0.1 | $84k | 20k | 4.20 |
